AMGN peer analysis
Amgen (AMGN) against its competitors: price, today's move, 1-year return and market value side by side.
AMGN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABBV AbbVie | $293.93 | -0.33% | 28.61% | $513.86B |
| AZN AstraZeneca | $184.31 | -1.25% | 11.92% | $270.48B |
| BMY Bristol-Myers Squibb | $62.53 | 0.08% | 36.56% | $125.49B |
| GSK GSK | $49.21 | -0.61% | 4.84% | $97.53B |
| JNJ Johnson & Johnson | $272.79 | -0.15% | 44.30% | $662.49B |
| LLY Eli Lilly | $1,403.25 | -1.01% | 66.48% | $1.22T |
| MRK Merck | $149.51 | -0.01% | 73.28% | $361.02B |
| NVS Novartis | $160.02 | -0.48% | 30.51% | $304.26B |
| PFE Pfizer | $30.56 | 0.13% | 25.61% | $170.71B |
| AMGN Amgen | $466.01 | 1.15% | 59.59% | $249.09B |
- AMGN's peers: ABBV (AbbVie), AZN (AstraZeneca), BMY (Bristol-Myers Squibb), GSK (GSK), JNJ (Johnson & Johnson), LLY (Eli Lilly), MRK (Merck), NVS (Novartis).
Updated 2026-11-02 17:56 UTC